Ekso Bionics (EKSO) Misses Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Ekso Bionics Reports Record Revenues of $4.7 Million in Second Quarter 2023
July 27, 2023 4:05 PM EDTSAN RAFAEL, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the Company), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and six months ended June 30, 2023.
Recent Highlights and Accomplishments
Achieved record revenues of $4.7 million in the second quarter of 2023, an increase of 36% year-over-yearBooked a total of 44 EksoHealth devices in the second quarter of... More